Evidence map›Paper›PMID 24992595›Full record

ArticleInternational journal of molecular sciences2014

Paeonol suppresses chondrosarcoma metastasis through up-regulation of miR-141 by modulating PKCδ and c-Src signaling pathway.

Chi-Ting Horng, Po-Chuen Shieh, Tzu-Wei Tan, Wei-Hung Yang, Chih-Hsin Tang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Plants (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Managing sarcoma: where have we come from and where are we going?Therapeutic advances in medical oncology · 2017
    Review
  18. Article
  19. MicroRNAs as biomarkers in the diagnosis and treatment of chondrosarcoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Review
  20. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Chi-Ting HorngMedical Education Center, Kaohsiung Armed Force General Hospital, Kaohsiung 802, Taiwan. mtc9042@yahoo.com.tw.
Po-Chuen ShiehDepartment of Pharmacy, Tajen University, Pingtung 907, Taiwan. pochuen@mail.tajen.edu.tw.
Tzu-Wei TanGraduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan. twtan@mail.cmu.edu.tw.
Wei-Hung YangDepartment of Orthopedic Surgery, Taichung Hospital, Ministry of Health and Welfare, Taichung 403, Taiwan. u766018@ms42.hinet.net.
Chih-Hsin TangGraduate Institute of Basic Medical Science, China Medical University, Taichung 404, Taiwan. twtan@mail.cmu.edu.tw.
Asia University · TWChina Medical University · TWKaohsiung Armed Forces General Hospital · TWNational Taichung University of Science and Technology · TWTajen University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chondrosarcoma, a primary malignant bone cancer, has potential for local invasion and distant metastasis, especially to the lungs. Patients diagnosed with it show poor prognosis. Paeonol (2'-hydroxy-4'-methoxyacetophenone), the main active compound of traditional Chinese remedy Paeonia lactiflora Pallas, exhibits anti-inflammatory and anti-tumor activity; whether paeonol regulates metastatic chondrosarcoma is largely unknown. Here, we find paeonol do not increase apoptosis. By contrast, at non-cytotoxic concentrations, paeonol suppresses migration and invasion of chondrosarcoma cells. We also demonstrate paeonol enhancing miR-141 expression and miR-141 inhibitor reversing paeonol-inhibited cell motility; paeonol also reduces protein kinase C (PKC)d and c-Src kinase activity. Since paeonol inhibits migration and invasion of human chondrosarcoma via up-regulation of miR-141 via PKCd and c-Src pathways, it thus might be a novel anti-metastasis agent for treatment of metastatic chondrosarcoma.

Indexed as

Up-RegulationAcetophenonesApoptosisCell Line, TumorCell MovementChondrosarcomaHumansMicroRNAsProtein Kinase C-deltaSignal Transductionsrc-Family KinasesAcetophenonesMicroRNAsMIRN141 microRNA, humanpaeonolProtein Kinase C-deltasrc-Family Kinases

Identifiers

PMID24992595
PMCPMC4139812
OpenAlexW2018790142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.